Title: Intravitreal Bevacizumab Treatment in a Patient with Subfoveal Choroidal Neovascularization Secondary to Choroidal Osteoma
Abstract: Purpose: To report the favorable response of choroidal neovascularization associated with choroidal osteoma to a single intravitreal injection of bevacizumab (Avastin). Methods: A 51-year-old male presented with decreased visual acuity and metamorphopsia in his right eye. Fundus photography, fluorescein angiography, indocyanine green angiography, optical coherence tomography, and visual acuity tests were performed. Under the diagnosis of classic choroidal neovascularization secondary to choroidal osteoma, the patient's right eye was treated with a single intravitreal injection of 1.25 mg bevacizumab. Results: Visual acuity in the right eye improved from counting fingers to 20/30. Resolution of both metamorphopsia and choroidal neovascularization were noted at 4 weeks post-treatment. Central foveal thickness decreased from 416 μm to 180 μm. At the final 6-month follow-up, the patient's visual acuity was maintained at 20/30 and he had experienced no complications. Conclusion: Intravitreal injection of bevacizumab can result in the regression of choroidal neovascularization secondary to choroidal osteoma.
Publication Year: 2009
Publication Date: 2009-12-01
Language: en
Type: article
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot